An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

NCT01018238 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped See detailed description

Conditions

Inflammation
Systemic Lupus Erythematosus

Interventions

DRUG: NNC 0151-0000-0000
DRUG: placebo

Sponsor

Novo Nordisk A/S